An N-terminal inhibitory domain modulates activity of FoxM1 during cell cycle

H J Park1, Z Wang, R H Costa

  • 1Department of Biochemistry and Molecular Genetics (M/C 669), College of Medicine, University of Illinois, Chicago, IL 60607, USA.

Oncogene
|September 25, 2007
PubMed

Insights

The FoxM1 protein

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • FoxM1 is a transcription factor crucial for cell proliferation and mitosis.
  • Its activity is regulated by phosphorylation and growth factors.

Purpose of the Study:

  • To investigate the role of the N-terminal inhibitory domain of FoxM1.
  • To understand how this domain affects FoxM1's transcriptional activity and cell cycle regulation.

Main Methods:

  • Deletion mutagenesis of the FoxM1 N-terminal domain.
  • Assays for transcriptional and transforming activities.
  • Cell cycle analysis and growth factor stimulation experiments.

Main Results:

  • Deleting the N-terminal 232 amino acids of FoxM1 enhances its activity.
  • The N-terminal deletion mutant shows constitutive high activity, independent of cyclin-cdk.
  • The N-terminal domain inhibits FoxM1 activity in G1/S phase cells.

Conclusions:

  • The N-terminal domain of FoxM1 acts as an inhibitor, counteracted by cyclin-cdk phosphorylation.
  • This regulation ensures FoxM1 is fully active during the G2/M phase for mitosis.
  • FoxM1's N-terminal domain plays a key role in cell cycle-dependent gene expression.

Related Concept Videos

Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
X-Inactivation01:58

X-Inactivation

The human X chromosome contains over ten times the number of genes as in the Y chromosome. Since males have only one X chromosome, and females have two, one might expect females to produce twice as many of the proteins, with undesirable results.
X-inactivation01:58

X-inactivation

The human X chromosome contains over ten times the number of genes as in the Y chromosome. Since males have only one X chromosome, and females have two, one might expect females to produce twice as many of the proteins, with undesirable results.